Enough pipeline but still missing target?

Your CRM says there’s enough opportunity. Pipeline coverage looks healthy. The sales team isn’t short of deals.

And yet the forecast keeps slipping and revenue is still behind target.

Before generating more leads, asking sellers to increase activity or buying more training, there is a more useful question.

How much of your pipeline do you actually believe?

Before generating more pipeline, check five things.

A full CRM is not the same as a healthy pipeline.

Imagine the team has £4m of pipeline against £1m of remaining target. On paper, that’s 4x coverage. It looks comfortable.

But suppose:

• £700k has had little meaningful customer progression
• £600k has already slipped its expected close date more than once
• £500k has no confirmed decision process
• £400k contains opportunities with weak qualification

The CRM still says £4m. The commercially credible number may look very different. That creates a distinction worth making explicitly.

Pipeline value and pipeline quality are not the same thing.

Coverage ratios are useful. But don’t treat a generic 3x or 4x rule as a universal truth. How much pipeline you need depends on your historical conversion, average deal value, sales-cycle length, opportunity quality, slippage and the type of sale.

A business converting 40% of credible opportunities does not require the same coverage as one converting 15%. Use your own commercial reality rather than somebody else’s benchmark.

If pipeline looks healthy but revenue doesn’t, check these five things.

The first question isn’t how much pipeline we have. It’s how much of it deserves to be called pipeline. For the opportunities the number depends on, ask:

• Is there a genuine customer problem?
• Is there evidence the customer intends to act, and do we understand why now?
• Have we reached the people who influence the decision?
• Is the opportunity value realistic?
• Is the close date based on something happening in the customer’s world?
• Is there a clear agreed next step, and has the customer taken meaningful action?

Avoid arbitrary rules such as declaring every opportunity dead after a fixed number of days. A complex enterprise opportunity behaves differently from a transactional B2B sale. The principle is simpler: the stage, value and close date should be supported by evidence.

A smaller pipeline of credible opportunities can be commercially healthier than a much larger pipeline filled with optimism.

Pipeline tells you how much opportunity exists. Conversion tells you how much of it becomes business. Look at win rate overall, then by seller, segment, source, product or service, stage, competitor and documented loss reason.

The immediate problem isn’t necessarily pipeline volume. The question becomes why conversion has fallen. Candidate causes include weak qualification, poor opportunity selection, ineffective discovery, insufficient stakeholder access, unclear value, pricing, competitive positioning, seller capability, weak opportunity strategy and manager involvement.

Don’t conclude that a low win rate automatically means sellers need closing training. The final loss may have been created much earlier.

Where are deals leaking?

Look at stage-to-stage conversion, not just Closed Won versus Closed Lost. Across a simple process — opportunity, qualified, discovery, solution or proposal, commercial decision, closed won — ask where the biggest drop is, where opportunities sit longest, at what stage customers stop taking meaningful action, where close dates begin moving, and which sellers have materially different stage conversion.

The final loss is often caused by something that happened several stages earlier.

A deal lost after proposal may look like a negotiation problem. But perhaps budget was never established, the decision maker was never involved, or there was never enough urgency to buy. That is why stage conversion matters.

A full pipeline can also fail to support target because opportunity values are unrealistic. Ask:

• How accurate are values early in the cycle?
• Do expected values shrink as deals progress?
• Are sellers entering aspirational values?
• Does coverage depend heavily on assumed expansion?
• Is there customer evidence supporting the expected value?

A £100k opportunity that repeatedly closes around £40k isn’t £100k of usable pipeline simply because the CRM says it is.

Where the data allows, compare initial opportunity value, progressed value and booked value. Patterns across the team reveal systematic inflation. The problem may not be insufficient pipeline. It may be overstated pipeline.

Enough opportunity can exist and still fail to produce revenue in the period you need it. Look at stage ageing, gaps between meaningful customer actions, repeated close-date changes, proposals waiting for decisions, procurement or legal delays, deals without agreed next steps, and differences between sellers.

A six-month enterprise sales cycle isn’t inherently unhealthy. A six-month opportunity in a sales motion that normally closes in eight weeks probably deserves investigation.

Compare cycle length and stage ageing against your own historic performance, customer segment, opportunity type, deal complexity and seller patterns rather than an external benchmark. And remember that a close date is only useful if something in the customer’s world makes it credible.

Pay attention to slippage

Ask what percentage of forecast opportunities close when expected, how many slip once, how many slip repeatedly, which stages create most slippage, which sellers carry the most slipped value, and what actually changed in the customer’s world.

Some delay is legitimate. But repeated, widespread slippage tends to point towards seller-created rather than customer-led dates, weak compelling events, poor access to decision makers, unclear procurement processes, optimistic forecasting or weak next-step discipline.

A £5m pipeline spread across 80 credible opportunities behaves differently from a £5m pipeline where £3m depends on four major deals. The headline number is identical. The risk is not.

• What percentage of pipeline sits in the largest five opportunities?
• What happens to coverage if the largest opportunity slips?
• Is pipeline concentrated among a handful of sellers?
• Is the team-level number disguising weak individual coverage?
• Is one segment responsible for disproportionate pipeline?

Pipeline coverage without concentration analysis can create false confidence.

Your CRM can be full while your credible pipeline is thin.

CRM pipeline drifts away from commercial reality gradually, and usually for understandable reasons:

• Weak opportunities are rarely closed out
• Old deals are carried indefinitely
• Close dates change without new customer evidence
• Sales stages are applied inconsistently
• Opportunity values are rarely updated
• Qualification standards are unclear
• Managers avoid removing weak opportunities because coverage would look worse

Removing weak pipeline makes the dashboard look worse before it makes the business easier to manage.

An honest £2.5m pipeline is more useful than a fictional £5m one.

Once weak opportunities are out, leaders can see the actual gap, and the decisions that follow — prospecting, account focus, coaching, deal strategy, forecasting, resource — are made against a real number. Accuracy is more useful than comfort.

More pipeline is only the answer when pipeline is actually the constraint.

If the team genuinely lacks credible opportunity, generating more is exactly the right response. But where enough credible opportunity already exists and the issue is quality, conversion, value or velocity, adding more opportunity mostly makes the existing problem larger.

• Weak qualification plus more leads: more weak opportunities.
• Low conversion plus more pipeline: more opportunities to lose.
• Slow progression plus more opportunity: a larger backlog of stalled deals.

Generate more pipeline when pipeline is the constraint. Fix conversion when conversion is the constraint.

Are managers improving pipeline quality — or simply reviewing it?

Managers set the standard for qualification, opportunity inspection, deal strategy, stage discipline, coaching, forecast judgement and next-step accountability. The pipeline review is where that standard is either applied or quietly dropped.

A pipeline review should improve the quality of the pipeline, not simply report its size.

A practical pipeline diagnostic.

If you can’t answer these confidently, the headline pipeline number isn’t giving you enough information.

Poor pipeline creates poor forecasts.

Forecasting sits downstream of pipeline quality. Where stages are unreliable, opportunity values are inflated, close dates continually move and weak deals stay open, forecast accuracy suffers regardless of the method used to produce the number.

Forecast accuracy starts with pipeline integrity.

What should I do if we have enough pipeline but we’re still missing target?

1. 1Validate the pipeline. Separate reported value from credible opportunity.
2. 2Find the leakage. Analyse overall and stage-to-stage conversion.
3. 3Validate the value. Check whether opportunity values reflect realistic commercial outcomes.
4. 4Analyse velocity and concentration. Identify ageing, slippage and dependence on a small number of opportunities.
5. 5Diagnose the cause. Determine whether the issue sits in qualification, capability, management, process, targeting or execution.
6. 6Intervene narrowly. Fix the constraint rather than launching a broad sales initiative.

Then measure again. Did the targeted behaviour change? Did the commercial signal move? Did more revenue result?

Pipeline is only one possible commercial constraint. For the broader diagnostic approach:

Why is my sales team missing target?→

A full pipeline isn’t the goal. Revenue is.

A healthy pipeline isn’t defined by how impressive the number looks in the CRM. It is defined by whether the opportunities are credible, qualified, progressing, convertible and valuable enough.

If pipeline is genuinely insufficient, build more. But if there is already enough reported opportunity, don’t automatically assume volume is the answer. Check quality, conversion, value, velocity and concentration, then diagnose what is driving the weakest area.

Pipeline tells you how much opportunity is there. Diagnosis tells you how much of it you should believe.

Frequently asked questions.

James King

Founder, Revenue Performance Partners

James works across sales performance, enablement and commercial operations, helping organisations diagnose performance gaps and turn them into measurable improvement.

More about James→